Related Experiment Video
Updated: Dec 18, 2025

06:38
Induction of Ocular Surface Inflammation and Collection of Involved Tissues
Published on: August 4, 2022
2.6K
Synthetic cannabinoid induced ocular self-injury
Kunal Malik1, Sumana Kommana1, Joshua Paul1
1Department of Ophthalmology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
Orbit (Amsterdam, Netherlands)
|June 20, 2020
Summary
Synthetic cannabinoid (K2) intoxication can cause severe neuropsychiatric effects. Two patients with schizophrenia self-injured their eyes while hallucinating, highlighting a new risk associated with these drugs.
Area of Science:
- Toxicology
- Psychiatry
- Ophthalmology
Background:
- Synthetic cannabinoids are popular recreational drugs with significant neuropsychiatric risks.
- Unlike natural cannabis, synthetic cannabinoids can cause severe toxicity.
- Untreated schizophrenia may increase vulnerability to drug-induced psychosis and injury.
Purpose of the Study:
- To report the first cases of ocular self-injury associated with synthetic cannabinoid intoxication.
- To highlight the potential for severe adverse events in vulnerable populations.
Main Methods:
- Case report of two patients presenting with ocular self-injury.
- Patients were intoxicated with synthetic cannabinoids (K2) and had a history of untreated schizophrenia.
- Clinical presentation and injury mechanism were documented.
Main Results:
- Both patients experienced visual hallucinations of a bug behind their eye.
- In attempts to remove the perceived bug, they caused significant damage to the periocular soft tissue.
- These injuries represent a novel form of self-harm linked to synthetic cannabinoid use.
Conclusions:
- Synthetic cannabinoid intoxication can lead to severe neuropsychiatric toxicity, including visual disturbances and self-harm.
- Ocular self-injury is a newly identified complication, particularly in individuals with pre-existing psychiatric conditions.
- Clinicians should be aware of these risks when evaluating patients with synthetic cannabinoid exposure.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
646
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
646
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
591
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
591

